TOP HEALTH INNOVATION FOUNDERS OF ATLANTIC CANADA IN 2023
In the serene landscapes of Atlantic Canada, where the rugged coastlines meet the vast expanse of the Atlantic Ocean, a wave of innovation is sweeping across the region. It’s not just about breathtaking natural beauty; it’s also about the remarkable strides being made in health innovation ventures.
The Atlantic Canada Health Scale-Up and Investment Challenge is partnered with Imaginal Ventures and Halo Health, funded by Nova Scotia Health Innovation Hub.
Let’s explore some ways in which this maritime haven is becoming a powerhouse of progress:
- Telemedicine Advancements: Telemedicine is booming in Atlantic Canada. From remote communities to city centers, healthcare services are becoming more accessible and efficient through telemedicine platforms. Patients can now receive consultations, diagnoses, and even treatment plans without the need to travel long distances.
- Digital Health: Startups and research institutions in the region are pioneering digital health solutions that are redefining patient care. Mobile apps, wearable devices, and telehealth platforms are connecting patients with healthcare professionals, helping to monitor chronic conditions, and even making early interventions.
- Biotechnology and Medical Devices: Biotech companies are flourishing in Atlantic Canada, focusing on pharmaceuticals, diagnostics, and medical devices. Innovations in these areas promise to improve patient outcomes and enhance the overall quality of healthcare services.
Atlantic Canada is emerging as a cradle of healthcare innovation, where cutting-edge technologies and forward-thinking solutions are transforming the way we approach wellness and healthcare. The region’s healthcare landscape is being reshaped by a commitment to innovation and collaboration.
Check out the Top Founders for the Atlantic Canada Health Scaleup & Investment Challenge below!
TOP ATLANTIC CANADA HEALTH FOUNDERS IN 2023
DeCell Technologies Inc.
DeCell Technologies Inc. (DeCell) is a biomedical technology and device company that develops advanced regenerative tissue matrices for clinical use in wound healing and surgical reconstructions.
Current methods for facilitating wound healing and treating conditions such as Diabetic Foot Ulcers (DFU’s) are costly, inefficient, and put the patient at risk of infection possibly resulting in limb loss if not healed quickly. DeCell’s patented prECMTM solution effectively accelerates wound healing and reduces healthcare costs by 50%. Clinicians in Alberta, Ontario, Nova Scotia and PEI are successfully healing their patients with our solution, improving the lives of so many Canadians who were living with chronic wounds.
AIMA Inc
AIMA, a queer female-led team, has developed clinically tested patent-pending products for personalized period pain management.
Amp Health
Amp Health is on a mission to prevent and manage chronic disease, beginning with type 2 diabetes.
Focusing on those at highest risk, Amp’s offerings help people keep blood sugar in range using behaviour change, real time patient data, and AI. With a key focus on U.N. Sustainable Development Goal (SDG) 3.4 (to lower the burden of noncommunicable chronic disease), Amp is also committed to SGD 5.5 (to ensure women’s full and effective participation and equal opportunities for leadership at all levels of decision making) and 8.5 (to achieve full and productive employment and decent work for all women and men, including for young people and persons with disabilities, and equal pay for work of equal value.)
Website | Linkedin
Au Naturel Solutions Inc.
Au Naturel Solutions Inc. created by Simonne Cormier, founder and CEO, is the first company to introduce a patented, all-natural materials handcrafted external breast prosthesis to the marketplace, filling a need for those looking for a natural alternative.
Comfort ‘n’ Confidence
external breast prostheses are perfect for people who experience; lumpectomy, mastectomy, natural asymmetry, and 2SLGBTQI+ gender expression. At Au Naturel Solutions Inc. we believe in community involvement, inclusive employment opportunities, and respect for employees, customers, and the environment.
Hollo Medical Inc.
Hollo Medical, based on feedback from over 1000 patients, caregivers and prescribers, has replaced the “thermos” with a device that takes as much space as a cell phone in a patient’s pocket. We designed it from the ground up to be discreet and easy to carry, so that patients can focus on what they love in life, and not what is holding them back.”
“Hundreds of millions of people worldwide reach for an inhaler when their breathing is impaired. But
90% of people use them improperly, resulting in only a fraction of the dose reaching the lungs where it is needed.
The current solution recommended by international guidelines, a thermos-sized tube between the
inhaler and the mouth, helps deliver the dose correctly. However, compliance is poor because they are
inconvenient and conspicuous, causing unnecessary hospitalization and side effects.
Inkwell Health Ltd.
Inkwell Health’s remote monitoring platform enhances physical therapy in-clinic visits with home monitoring to ensure patients complete treatments, avoid complications, and improve clinic revenues through the process after a knee surgery or injury.
John Matthews is CEO of InkWell Health and has over 25 years of sales leadership and executive leadership experience. He has delivered on an exit, led multiple acquisitions, assisted in the launch of a new global company, and the divestiture of a global business, as well as led multiple novel product launches in the US and globally.
MeddAI Medical Inc.
MeddAI Medical Inc. is at the forefront of revolutionizing cancer care with its state-of-the-art technological solutions. Founded in Canada with a heartfelt mission, the company stands on the pillars of early detection, effective treatment, and creating a lifesaving impact in the realm of cancer care.
Embracing the power of advanced AI and data analytics, MeddAI boasts an impressive 99% accuracy rate in cancer screening, backed by its vast dataset of over a billion data points. These data-driven insights are fundamental to the company’s innovative algorithms, ensuring accurate and timely results for patients globally.
MIMOSA Diagnostics
MIMOSA Diagnostics Inc. is a leading provider of intuitive, equitable, and accessible healthcare technology.
Their flagship product, the MIMOSA Pro is a pocket-sized imaging device that streamlines tissue health assessments for clinicians by capturing temperature, tissue oxygenation, and digital images in less than one second. The images are then uploaded to a HIPAA-compliant web portal where clinicians can monitor patient progress, identify early opportunities for intervention, and collaborate towards improved patient outcomes.
Mobia Health Innovations
Mobia Health is a Software as a Service (SaaS) product company with transformative solutions to improve the patient journey and clinical workloads.
NeoCare
NeoCare, a Canadian medtech company develops non-invasive and painless methods of disease detection in new born babies.
Our flagship product SAMIRA provides painless, instantaneous and stress-free solution to the new born/parents for determination anemia, jaundice and hypoxia unlike conventional methods involving multiple needle pricks at an affordable cost
Parados
Parados helps elite performance and medical movement specialists analyze key biometrics on easy-to-interpret dashboards. In the short-term, we are a ‘rapid-test’ to remove accessibility and time barriers with the long-term vision of providing a ‘build-your-own’ motion capture system.
The platform uses computer vision AI to create 3D digital models of individuals for accessible, instant and objective physical evaluations. Traditionally these technologies require expensive equipment, experts and large designated spaces.
Using the platform is as simple as uploading video(s) from mobile devices to receive quantified results within seconds to support proactive & personalized approaches through asynchronous remote evaluations, client monitoring over time, downloading/sharing reports between specialists, and more.
Dr. Gordon’s/Scotiaderm Inc.
Scotiaderm is a Nova Scotian company led by CMO, Dr. Ann Gordon and CEO, Johanna Mercer. Dermategrity – previously known as Dr. Gordon’s Bum Cream (DGBC) – is our slate of accessible, proprietary OTC and Natural topical solutions for the Prevention and Treatment of Moisture Associated Skin Damage (MASD) – including Incontinence Associated Dermatitis (IAD) and Intertrigo (ITD).
MASD is a stigmatized Primary Care or Nursing problem disproportionately affecting elderly, female, obese and immobile persons. It can be chronic, painful and expensive to treat. A lack of interest has resulted in astonishingly poor funding, research, literature, innovation and guidance. Our Mission is to improve the standard of care.